Small extracellular vesicles from deferoxamine-primed stem cells promote angiogenesis and tissue integration.

Authors

Jingyi Sang, Yuqing Dong, Xiaoyue Zhang, Xiaojing Yuan, Yike Gao, Rui Song, Xiya Liu, Linxue Zhang, Zuoying Yuan, Yuming Zhao

Published in

Extracellular vesicles and circulating nucleic acids. Volume 7. Issue 3. Pages 1428-1444. Epub Sep 08, 2026.

Abstract

Aim: We investigated whether the secretome, particularly small extracellular vesicles (sEVs), obtained from deferoxamine (DFO)-pretreated stem cells from human exfoliated deciduous teeth (SHED), could promote angiogenesis in human umbilical vein endothelial cells (HUVECs) and support vascularized tissue integration under preliminary ectopic implantation conditions. Methods: SHED were treated with DFO (2.5, 5, 10 μM), and RNA sequencing was performed to analyze gene expression changes in DFO-treated SHED. The effects of the DFO-pretreated SHED secretome and the isolated sEVs (DFO-sEVs) on HUVEC migration were evaluated. The angiogenic capacity was assessed using wound healing, Transwell migration, and tube formation assays. DFO-sEVs were also tested for their ability to regulate macrophage polarization using immunofluorescence staining. Finally, DFO-sEVs were encapsulated in hydrogels and subcutaneously implanted into Sprague-Dawley rats, and their pro-angiogenic capacity in vivo was assessed via histological staining. Results: RNA-seq analysis indicated that DFO pretreatment modulated SHED pathways related to hypoxia response, cell adhesion, and inflammation. The secretome from SHED pretreated with 5 μM DFO significantly promoted HUVEC migration and tube formation. DFO-sEVs, particularly from the 5 μM DFO group, demonstrated superior pro-angiogenic effects compared to sEVs from untreated SHED both in vitro and in vivo. Furthermore, DFO-sEVs drove macrophages to adopt an M2-like reparative polarization. Conclusion: DFO pretreatment functionally potentiates the pro-angiogenic and immunomodulatory properties of SHED-derived sEVs. The findings suggest that DFO-sEVs may provide a bioactive component for promoting angiogenesis and facilitating tissue integration.

PMID:
42891114
Bibliographic data and abstract were imported from PubMed on 18 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.